Details for New Drug Application (NDA): 020355
✉ Email this page to a colleague
NDA 020355 describes STIMATE (NEEDS NO REFRIGERATION), which is a drug marketed by Ferring Pharms Inc and is included in one NDA. Additional details are available on the STIMATE (NEEDS NO REFRIGERATION) profile page.
The generic ingredient in STIMATE (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
The generic ingredient in STIMATE (NEEDS NO REFRIGERATION) is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 020355
| Tradename: | STIMATE (NEEDS NO REFRIGERATION) |
| Applicant: | Ferring Pharms Inc |
| Ingredient: | desmopressin acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.15MG/SPRAY | ||||
| Approval Date: | Mar 7, 1994 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.15MG/SPRAY | ||||
| Approval Date: | Oct 24, 2007 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
